Neil Carleton, PhD

Onkar SS, Carleton NM, Lucas PC, Bruno TC, Lee AV, Vignali DAA, Oesterreich S. The Great Immune Escape: Understanding the Divergent Immune Response in Breast Cancer Subtypes. Cancer Discov. 2023 Jan 9;13(1):23-40. doi: 10.1158/2159-8290.CD-22-0475. PMID: 36620880; PMCID: PMC9833841.

Carleton, N., Abidi, H., Puthanmadhom-Narayanan, S., Marroquin, O. C., Oesterreich, S., Diego, E. J., Brufsky, A. M., Lee, A. V., & McAuliffe, P. F. (2023). Omission of surgery, primary endocrine therapy adherence, and effect of comorbidity in older women with estrogen receptor positive breast cancer. Journal of Geriatric Oncology, 101679–101679. https://doi.org/10.1016/j.jgo.2023.101679

Steffi Oesterreich, PhD, Azadeh Nasrazadani, MD, PhD, Jian Zou, MS, Neil Carleton, BS, Tiffany Onger, MD, Matthew D Wright, MD, Yujia Li, BS, Kathryn Demanelis, PhD, Bhuvaneswari Ramaswamy, MD, George Tseng, PhD, Adrian V Lee, PhD, Nicole Williams, MD, Megan Kruse, MD, Clinicopathological Features and Outcomes Comparing Patients With Invasive Ductal and Lobular Breast Cancer, JNCI: Journal of the National Cancer Institute, 2022;, djac157, https://doi.org/10.1093/jnci/djac157

Carleton, N., McAuliffe, P.F. Are the chronological age cutoffs used in clinical oncology guidelines biologically meaningful?. Nat Rev Clin Oncol (2022). https://doi.org/10.1038/s41571-022-00684-4

Carleton N, Nasrazadani A, Gade K, Beriwal S, Barry PN, Brufsky AM, Bhargava R, Berg WA, Zuley ML, Marroquin OC, Thull DL, Mai PL, Diego EJ, Lotze MT, Oesterreich S, McAuliffe PF, Lee AV. Personalizing Therapy for Early-Stage ER+ Breast Cancer in Older Women. The Lancet Healthy Longevity. 2021 Nov 9. In Press.
 
Carleton N, Zou J, Fang Y, Koscumb SE, Shah OS, Chen F, Beriwal S, Diego EJ, Brufsky AM, Oesterreich S, Shapiro SD, Ferris R, Emens LA, Tseng G, Marroquin OC, Lee AV, McAuliffe PF. Outcomes After Sentinel Lymph Node Biopsy and Radiotherapy in Older Women With Early-Stage, Estrogen Receptor-Positive Breast Cancer. JAMA Netw Open. 2021 Apr 1;4(4):e216322. doi: 10.1001/jamanetworkopen.2021.6322. PubMed PMID: 33856473; PubMed Central PMCID: PMC8050744.
 
Lee JL, Ekambaram P, Carleton NM, Hu D, Klei LR, Cai Z, Myers MI, Hubel NE, Covic L, Agnihotri S, Krappmann D, Bornancin F, Lee AV, Oesterreich S, McAllister-Lucas L, Lucas PC. MALT1 is a Targetable Driver of Epithelial-to-Mesenchymal Transition in Claudin-low, Triple-Negative Breast Cancer. Mol Cancer Res. 2021 Nov 9;. doi: 10.1158/1541-7786.MCR-21-0208. [Epub ahead of print] PubMed PMID: 34753803.
 
Chen F, Ding K, Priedigkeit N, Elangovan A, Levine KM, Carleton N, Savariau L, Atkinson JM, Oesterreich S, Lee AV. Single-Cell Transcriptomic Heterogeneity in Invasive Ductal and Lobular Breast Cancer Cells. Cancer Res. 2021 Jan 15;81(2):268-281. doi: 10.1158/0008-5472.CAN-20-0696. Epub 2020 Nov 4. PubMed PMID: 33148662; PubMed Central PMCID: PMC7856056.
 
Ghosh-Choudhary S, Carleton N, Flynn JL, Kliment CR. Strategies for Achieving Gender Equity and Work-Life Integration in Physician-Scientist Training. Acad Med. 2021 Jul 20;. doi: 10.1097/ACM.0000000000004246. [Epub ahead of print] PubMed PMID: 34292189.